Bionano Genomics (BNGO) Competitors $4.10 +0.10 (+2.50%) Closing price 03:58 PM EasternExtended Trading$4.10 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNGO vs. AATC, DAIO, CLIR, MSAI, STAI, PRPO, ASTC, TLIS, SMIT, and TBIOShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Autoscope Technologies (AATC), Data I/O (DAIO), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), ScanTech AI Systems (STAI), Precipio (PRPO), Astrotech (ASTC), Talis Biomedical (TLIS), Schmitt Industries (SMIT), and Telesis Bio (TBIO). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Its Competitors Autoscope Technologies Data I/O ClearSign Technologies MultiSensor AI ScanTech AI Systems Precipio Astrotech Talis Biomedical Schmitt Industries Telesis Bio Autoscope Technologies (NASDAQ:AATC) and Bionano Genomics (NASDAQ:BNGO) are both small-cap measuring and control equipment companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Do insiders & institutionals believe in AATC or BNGO? 11.4% of Bionano Genomics shares are owned by institutional investors. 21.6% of Autoscope Technologies shares are owned by insiders. Comparatively, 0.9% of Bionano Genomics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is AATC or BNGO more profitable? Autoscope Technologies has a net margin of 37.59% compared to Bionano Genomics' net margin of -271.02%. Autoscope Technologies' return on equity of 27.06% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Autoscope Technologies37.59% 27.06% 23.97% Bionano Genomics -271.02%-129.41%-72.25% Does the media favor AATC or BNGO? In the previous week, Bionano Genomics had 11 more articles in the media than Autoscope Technologies. MarketBeat recorded 11 mentions for Bionano Genomics and 0 mentions for Autoscope Technologies. Autoscope Technologies' average media sentiment score of 0.98 beat Bionano Genomics' score of 0.82 indicating that Autoscope Technologies is being referred to more favorably in the media. Company Overall Sentiment Autoscope Technologies Positive Bionano Genomics Positive Which has stronger earnings and valuation, AATC or BNGO? Autoscope Technologies has higher earnings, but lower revenue than Bionano Genomics. Bionano Genomics is trading at a lower price-to-earnings ratio than Autoscope Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutoscope Technologies$12.89M3.12$6.62M$0.5912.42Bionano Genomics$30.78M0.62-$112.02M-$138.92-0.03 Do analysts recommend AATC or BNGO? Bionano Genomics has a consensus price target of $7.50, indicating a potential upside of 82.93%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts plainly believe Bionano Genomics is more favorable than Autoscope Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autoscope Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has more volatility and risk, AATC or BNGO? Autoscope Technologies has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Bionano Genomics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. SummaryAutoscope Technologies beats Bionano Genomics on 9 of the 16 factors compared between the two stocks. Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.19M$3.06B$5.75B$9.73BDividend YieldN/A2.24%4.40%4.10%P/E Ratio-0.0320.9930.2525.89Price / Sales0.62387.70474.39123.10Price / CashN/A43.2325.7828.79Price / Book0.239.639.426.00Net Income-$112.02M-$54.08M$3.27B$265.29M7 Day Performance30.16%2.70%2.08%2.59%1 Month Performance21.30%4.14%3.63%0.98%1 Year Performance-87.01%9.46%30.13%18.75% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics2.2829 of 5 stars$4.10+2.5%$7.50+82.9%-87.3%$19.19M$30.78M-0.03300Analyst UpgradeAATCAutoscope Technologies1.8205 of 5 stars$7.06+0.1%N/A+1.1%$38.76M$12.89M8.0240DAIOData I/O1.6177 of 5 stars$3.32+0.3%$5.22+57.2%+9.9%$31.18M$21.77M-11.86100CLIRClearSign Technologies2.3826 of 5 stars$0.56-0.4%$2.00+257.1%-27.3%$29.36M$3.60M-5.0910Gap UpMSAIMultiSensor AI3.0436 of 5 stars$0.77-1.8%$2.50+226.4%-65.7%$26.48M$6.30M0.0035STAIScanTech AI SystemsN/A$0.50-1.8%N/AN/A$24.13M$540K0.00N/AGap DownPRPOPrecipio0.7248 of 5 stars$14.40-2.1%N/A+109.7%$23.33M$20.03M-12.1060High Trading VolumeASTCAstrotech0.5896 of 5 stars$5.07+0.8%N/A-56.2%$8.57M$1.66M-0.6010Gap UpTLISTalis BiomedicalN/A$1.50flatN/A-66.8%$2.73M$300K-0.05260SMITSchmitt IndustriesN/A$0.02-27.6%N/AN/A$69K$9.89M0.00160Gap DownTBIOTelesis BioN/A$0.02flatN/A-99.4%$40K$225.09M0.00200 Related Companies and Tools Related Companies AATC Alternatives DAIO Alternatives CLIR Alternatives MSAI Alternatives STAI Alternatives PRPO Alternatives ASTC Alternatives TLIS Alternatives SMIT Alternatives TBIO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNGO) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access